Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
54.82%
operating margin TTM
44.93%
revenue TTM
53.06 Million
revenue per share TTM
1.8$
valuation ratios | |
|---|---|
| pe ratio | 39.34 |
| peg ratio | 0.63 |
| price to book ratio | 7.07 |
| price to sales ratio | 21.77 |
| enterprise value multiple | 45.83 |
| price fair value | 7.07 |
profitability ratios | |
|---|---|
| gross profit margin | 93.34% |
| operating profit margin | 44.93% |
| pretax profit margin | 51.45% |
| net profit margin | 54.82% |
| return on assets | 16.09% |
| return on equity | 19.34% |
| return on capital employed | 14.41% |
liquidity ratios | |
|---|---|
| current ratio | 8.32 |
| quick ratio | 7.96 |
| cash ratio | 3.36 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 566.73 |
| operating cycle | 681.63 |
| days of payables outstanding | 81.41 |
| cash conversion cycle | 600.22 |
| receivables turnover | 3.18 |
| payables turnover | 4.48 |
| inventory turnover | 0.64 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.01 |
| debt equity ratio | 0.01 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.01 |
| interest coverage | 0.00 |
| cash flow to debt ratio | 30.76 |
cash flow ratios | |
|---|---|
| free cash flow per share | 8.73 |
| cash per share | 28.64 |
| operating cash flow per share | 9.22 |
| free cash flow operating cash flow ratio | 0.95 |
| cash flow coverage ratios | 30.76 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | 18.71 |
Frequently Asked Questions
When was the last time Krystal Biotech, Inc. (NASDAQ:KRYS) reported earnings?
Krystal Biotech, Inc. (KRYS) published its most recent earnings results on 03-08-2026.
What is Krystal Biotech, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Krystal Biotech, Inc. (NASDAQ:KRYS)'s trailing twelve months ROE is 19.34%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Krystal Biotech, Inc. (KRYS) currently has a ROA of 16.09%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did KRYS's net profit margin stand at?
KRYS reported a profit margin of 54.82% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is KRYS's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 8.32 in the most recent quarter. The quick ratio stood at 7.96, with a Debt/Eq ratio of 0.01.